Profile: Medtronic PLC (MDT.N)

MDT.N on New York Stock Exchange

74.46USD
5 Feb 2016
Change (% chg)

$-1.74 (-2.28%)
Prev Close
$76.20
Open
$76.14
Day's High
$76.14
Day's Low
$74.09
Volume
1,836,807
Avg. Vol
2,029,405
52-wk High
$79.50
52-wk Low
$55.54

Search Stocks

Medtronic plc. (Medtronic) incorporated on April 23 1957 is a medical technology company. The Company offers its products to hospitals, physicians, clinicians and patients in over 140 countries. The Company operates in three segments: Cardiac and Vascular Group Restorative Therapies Group and Diabetes Group. The Cardiac and Vascular Group segment manufactures and markets devicebased medical therapies for Cardiac Rhythm Disease Management (CRDM) Coronary Structural Heart and Endovascular. The Restorative Therapies Group segment manufactures and markets devicebased medical therapies for Spine Neuromodulation and Surgical Technologies. The Diabetes Group segment manufactures and markets devicebased medical therapies for diabetes. The Company offers Heli-FX and Heli-FX Thoracic EndoAnchor systems that feature an endovascular deployed anchor designed to attach a variety of aortic endografts to the native vessel wall. The Company’s ANCHOR Registry, which is a post-market registry evaluating the Heli-FX Aortic Securement System. The Company is also focused on the distribution of TourGuide Steerable Sheath, a device with adjustable tip that enables access and delivery of peripheral vascular products, in the United States and Europe.

Cardiac Rhythm Disease Management

CRDM develops manufactures and markets products for the diagnosis treatment and management of heart rhythm disorders and heart failure including implantable devices leads and delivery systems products for the treatment of atrial fibrillation (AF) products designed to reduce surgical site infections information systems for the management of patients with CRDM devices and an integrated health solutions business.

The Company's Implantable Cardiac Pacemakers (Pacemakers) are batterypowered device implanted in the chest that delivers electrical impulses to treat bradycardia a condition of abnormally slow heart rhythms usually less than 60 beats per minute or unsteady heart rhythms that cause symptoms such as dizziness fainting fatigue and shortness of breath. The Company's pacemaker systems are compatible with certain magnetic resonance imaging (MRI) machines. These include the Advisa and Revo MRI SureScan models and the Advisa and Ensura MRI SureScan models. The Company also markets the Adapta product family which includes the Adapta Versa and Sensia models.

The Company's Implantable Cardioverter Defibrillators (ICDs) monitor the heart and delivers therapy when an abnormal heart rhythm such as tachyarrhythmia or rapid heart rhythm occurs and leads to sudden cardiac arrest. Medtronic's ICD is the Evera MRI SureScan which is used for fullbody MRI scans. The Evera system is paired with the Sprint Quattro Secure lead a defibrillator lead with active monitoring. In addition to Evera devices in the ICD family include the Protecta XT/Protecta with SmartShock technology including the Lead Integrity Alert (LIA) a technology designed to detect lead fractures and the Cardia and Egida models. The Company also continues to market the Secura Virtuoso and Maximo II devices.

The Company's Implantable Cardiac Resynchronization Therapy Devices (CRTDs and CRTPs) are combined with defibrillation (CRTD) or are pacingonly (CRTP). These devices treat heart failure patients by altering the abnormal electrical sequence of cardiac contractions by sending tiny electrical impulses to the lower chambers of the heart. The Company's CRTDs include the Viva/Brava family that features a new algorithm called AdaptivCRT which improves heart failure patients' response rate to CRTD therapy. In Europe Medtronic also offers Attain Performa quadripolar leads. Paired with the Company's Viva/Brava Quad CRTDs Attain Performa leftheart leads provide additional options for physicians as they navigate different patient anatomies optimizing therapy based on the individual needs of heart failure patients. Its CRTD devices also include the Protecta XT/Protecta with SmartShock technology. In the United States its CRTP devices are Consulta and Syncra.

AF Products

The Company's portfolio of AF products includes the Arctic Front Advance Cardiac Cryoballoon System designed for pulmonary vein isolation in the treatment of patients with drug refractory paroxysmal AF. Additionally it also has a Phased RF System PVAC Gold which uses duty cycled phased radio frequency energy for the treatment of symptomatic paroxysmal persistent and longstanding persistent AF.

Diagnostics and Monitoring Devices

The Reveal LINQ is the Company's newest Insertable Cardiac Monitor (ICM) System. The system is used to record the heart's electrical activity before during and after transient symptoms such as syncope (fainting) and palpitations to help provide a diagnosis.

Services and Solutions

The Company's Cardiocom products and services include remote monitoring and patientcentered software to enable efficient care coordination and specialized telehealth nurse support. Its TYRX products include AIGISRx R fully resorbable antibacterial envelope and AIGISRx N antibacterial envelope which are designed to reduce surgical site infections associated with implantable pacemakers defibrillators and spinal cord neurostimulators. Its Cath Lab Managed Services business is focused on developing partnerships with hospitals to provide services directly related to the hospital.

Patient Management Tools

Medtronic has a number of patient management tools such as Patient Home Monitors CareLink Express Paceart and CardioSight Service. CareLink Express is used for the care of Medtronic cardiac device patients enabling transmission of data from their pacemaker ICD CRTD or Insertable Cardiac Monitor using a portable monitor that is connected to a standard telephone line. Paceart organizes and archives data for cardiac devices from major device manufacturers serving as the central hub for patients' device data. CardioSight Service is an inclinic data access tool available to physicians treating heart failure patients who have one of several types of Medtronic CRTDs or ICDs. Patient Home Monitors transfer data from pacemakers ICDs and CRTDs from patients' homes to a webbased system that their health care provider can view.

The Company competes with St. Jude Medical Inc. (St. Jude) Boston Scientific Corporation (Boston Scientific) Biotronik Inc. and Sorin Group (Sorin).

Company Address

Medtronic PLC

20 On Hatch, Hatch Street Lower
DUBLIN     2
P: +3531.4381700

Company Web Links

Search Stocks